About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | 4-methylpyrazole and Acetaminophen Metabolism

4-methylpyrazole and Acetaminophen Metabolism

NCT03878693·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Arizona

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Healthy
No APAP use in previous 2 weeks
No ingestion of alcohol or drugs that affect CYP 2E1 over previous 5 days
No allergy to APAP or fomepizole
BMI \< 29

You may not be if

Pregnant or lactating
History of alcohol abuse
Allergy to APAP or fomepizole
Screening LFTs above normal range

The record

StatusCompleted

PhaseEarly phase 1

Taking part6

StartedJul 2018

UpdatedSep 26, 2019

Conditions

Healthy Adult Volunteers

Where1

BUMCP - Department of Medical Toxicology
Phoenix, Arizona, United States